Associated Milestones. 4 a. No later than 60 days before January 17, 2025 (i.e. by November 18, 2024), the 5 Parties shall meet and confer to discuss whether EPA expects to issue a final Insecticide Strategy by 6 January 17, 2025. Within 10 days after the Parties’ meet and confer (i.e. by November 29, 2024), EPA 7 shall provide a status report to the Court on its progress toward completing the final Insecticide Strategy 8 and the outcome of the Parties’ meet and confer.
9 b. No later than July 30, 2024, EPA commits to provide the draft Insecticide 10 Strategy for a 60-day public comment period. EPA does not currently expect to extend the public 11 comment period beyond 60 days.
12 c. When EPA issues the above-referenced final Insecticide Strategy, it will include a 13 Response to Comments document for comments received during the public comment period on the draft 14 Insecticide Strategy.
15 d. Once EPA issues the final Insecticide Strategy, EPA shall consider incorporating 16 and expects to incorporate the mitigation measures identified in the Insecticide Strategy into PIDs issued 17 under EPA’s registration review program. Where EPA finds that groups of insecticides should receive 18 the same mitigation measures, EPA may issue group PIDs, instead of chemical-specific ones, where 19 appropriate.
20 e. EPA will make any PIDs available for a 60-day public comment period and does 21 not currently anticipate extending the public comment period beyond 60 days.
Associated Milestones. 21 i. No later than 90 days prior to the commitment to complete draft 22 carbaryl and methomyl Biological Evaluations identified above, EPA shall provide a status
1 Evaluations and whether it expects to meet that commitment. As part of this status report, EPA 2 will address any issues the agency has identified, in the process of developing the carbaryl and 3 methomyl Biological Evaluations, as it relates to the role of use and usage data in the Biological 4 Evaluations.
5 ii. No later than 90 days prior to the deadline to complete final 6 carbaryl and methomyl Biological Evaluations identified above, EPA shall provide a status 7 report to the Court and other Parties on its progress toward completing those final Biological 8 Evaluations and whether it expects to meet that deadline.
9 iii. If the final Biological Evaluations deadline in Paragraph 1.a. is 10 extended pursuant to the procedures described in Paragraph 1.c. herein, the dates for completing 11 the milestones in this subsection will be extended correspondingly.
Associated Milestones. 7 i. No later than 90 days prior to the commitment to complete draft 8 atrazine and simazine Biological Evaluations identified above, EPA shall provide a status report 9 to the Court and other Parties on its progress toward completing those draft Biological 10 Evaluations and whether it expects to meet that commitment.
11 ii. No later than 90 days prior to the deadline to complete final 12 atrazine and simazine Biological Evaluations identified above, EPA shall provide a status report 13 to the Court and other Parties on its progress toward completing those final Biological 14 Evaluations and whether it expects to meet that deadline.
15 iii. If the final BE deadline in Paragraph 2.a. is extended pursuant to 16 the procedures discussed in Paragraph 2.c. herein, the dates for completing the milestones in this 17 subsection will be extended correspondingly.
Associated Milestones. 14 i. No later than 90 days prior to the commitment to complete draft 15 brodifacoum, bromadiolone, warfarin, zinc phosphide Biological Evaluations identified above, 16 EPA shall provide a status report to the Court and other Parties on its progress toward 17 completing those draft Biological Evaluations and whether it expects to meet that commitment.
18 ii. No later than 90 days prior to the deadline to complete final 19 brodifacoum, bromadiolone, warfarin, zinc phosphide Biological Evaluations identified above, 20 EPA shall provide a status report to the Court and other Parties on its progress toward 21 completing those final Biological Evaluations and whether it expects to meet that deadline.
1 iii. If the final Biological Evaluation deadline in Paragraph 3.a. is 2 extended pursuant to the procedures described in Paragraph 3.c. herein, the dates for completing 3 the milestones in this subsection will be extended correspondingly.
Associated Milestones. 7 i. No later than March 31, 2027, EPA commits to issue a draft Organophosphates 8 Biological Evaluation, as well as provide notice and a 60-day opportunity for public comment on the 9 draft Biological Evaluation.
10 ii. No later than 90 days prior to the commitment to complete a draft 11 Organophosphates Biological Evaluation identified above, EPA shall provide a status report to the Court 12 and other Parties on its progress toward completing the draft Biological Evaluation and whether it 13 expects to meet that commitment.
14 iii. No later than 60 days prior to the deadline to complete the final 15 Organophosphates Biological Evaluations identified above, EPA shall provide a status report to the 16 Court and other Parties on its progress toward completing the final Biological Evaluations and whether 17 it expects to meet that deadline.
Associated Milestones. 15 a. No later than November 12, 2023, EPA commits to issue draft Biological 16 Evaluations for Brodifacoum, Bromadiolone, Warfarin, and Zinc Phosphide, as well as provide notice 17 and a 60-day opportunity for public comment on the draft Biological Evaluations.
18 b. No later than 90 days prior to the commitment to complete draft 19 Biological Evaluations for Brodifacoum, Bromadiolone, Warfarin, and Zinc Phosphide, EPA shall 20 provide a status report to the Court and other Parties on its progress toward completing the draft 21 Biological Evaluations and whether it expects to meet that commitment.
22 c. No later than 90 days prior to the deadline to complete final Biological 23 Evaluations for Brodifacoum, Bromadiolone, Warfarin, and Zinc Phosphide, EPA shall provide a status 24 report to the Court and other Parties on its progress toward completing the final Biological Evaluations 25 and whether it expects to meet that deadline.
1 d. If the final Biological Evaluation deadline in Paragraph I.B.1. is extended 2 pursuant to the procedures described below in Paragraph I.B.3., the dates for completing the milestones 3 in this subsection will be extended correspondingly.
Associated Milestones. 4 a. No later than 60 days before May 30, 2024, EPA shall provide a status report to 5 the Court and other Parties on its progress toward completing the final Herbicide Strategy by May 30, 6 2024 and whether it expects to meet that commitment.
7 b. When EPA issues its final Herbicide Strategy, it will include a Response to 8 Comments document for comments received during the public comment period on the draft Herbicide 9 Strategy that was issued on July 24, 2023.
10 c. Once EPA issues the final Herbicide Strategy, EPA shall consider incorporating 11 and expects to incorporate the mitigation measures identified in the Herbicide Strategy into PIDs issued 12 under EPA’s registration review program. Where EPA finds that groups of herbicides should receive the 13 same mitigation measures, EPA plans to issue group PIDs, instead of chemical-specific ones, where 14 appropriate.
15 d. EPA will make any PIDs available for a 60-day public comment period and does 16 not currently anticipate extending the public comment period beyond 60 days.
